Essential fatty acids enhance free radical generation and lipid peroxidation to induce apoptosis of tumor cells

Clinical Lipidology

Volumn 6, Issue 4, 2011, Pages 463-489

  Das, Undurti N ^a,b  

^a UND LIFE SCIENCES   (United States)

^b JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

Author keywords

linolenic acid; antioxidants; apoptosis; arachidonic acid; cancer; catalase; docosahexaenoic acid; eicosapentaenoic acid; free radicals; lipid peroxides; normal cells; oncogenes; polyunsaturated fatty acids; superoxide dismutase; vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANGIOSTATIN; ANTINEOPLASTIC AGENT; ARACHIDONIC ACID; BEVACIZUMAB; BLEOMYCIN; CETUXIMAB; COPPER ZINC SUPEROXIDE DISMUTASE; CYCLOOXYGENASE 2; DOCOSAHEXAENOIC ACID; DOXORUBICIN; ENDOSTATIN; ESSENTIAL FATTY ACID; FREE RADICAL; GROWTH FACTOR; ICOSAPENTAENOIC ACID; LIPID PEROXIDE; LITHIUM GAMMA LINOLENIC ACID; MANGANESE SUPEROXIDE DISMUTASE; MONOCLONAL ANTIBODY; NANOPARTICLE; POLYUNSATURATED FATTY ACID; PROTEIN BCL 2; PROTEIN P53; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; TELOMERASE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL DESTRUCTION; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CELL ACTIVITY; CELL FUNCTION; CELL PROLIFERATION; CYTOTOXICITY TEST; DRUG CONJUGATION; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; DRUG SENSITIVITY; ENZYME INHIBITION; FATTY ACID METABOLISM; GLIOMA; HUMAN; IODINATION; LIPID PEROXIDATION; MACROPHAGE; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TUMOR CELL;

EID: 80051981196     PISSN: 17460875     EISSN: 17584302     Source Type: Journal    
DOI: 10.2217/clp.11.34     Document Type: Review

References (254)

1. Casppary WJ, Niziak C, Lanzo DA, Friedman R, Bachur NR. Bleomycin A2: a ferrous oxidase. Mol. Pharmacol. 16, 256-260 (1979)
2. Young, RC, Ozols RF, Myers CE. The anthracycline antineoplastic drugs. N. Engl J. Med. 305, 139-153 (1981) (Pubitemid 11073081)
3. Gajewski E, Rao G, Nackerdien Z, Dizdaroglu M. Modification of DNA bases in mammalian chromatin by radiation-generated free radicals. Biochemistry 29, 7876-7882 (1990) (Pubitemid 20281235)
4. Das UN. Oxy radicals and their clinical implications. Curr. Sci. 65, 964-968 (1993)
5. Das UN. Free radicals, Biology and relevance to disease. J. Assoc. Phy. Ind. 38, 495-498 (1990)
6. Halliwell BA. Superway to kill cancer cells? Nature Med. 6, 1105-1106 (2000)
7. Cleveland JL, Kastan MB. A radical approach to treatment. Nature 407, 309-311 (2000)
8. Sunderesan M, Yu ZX, Ferrans VJ, Irani K, Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270, 296-299 (1995)
9. Suderesan M, Yu ZX, Ferrans VJ, et al. Regulation of reactive-oxygen- species generation in fibroblasts by Rac1. Biochem. J. 318, 379-382 (1996) (Pubitemid 26305933)
10. Jayanthi S, Ordonez S, McCoy MT, Cadet JL. Dual mechanism of Fas-induced cell death in neuroglioma cells, a role for reactive oxygen species. Brain Res. Mol. Brain Res. 72, 158-165 (1999) (Pubitemid 29472401)
11. Wang S, Leonard SS, Ye J, Ding M, Shi X. The role of hydroxyl radical as a messenger in Cr(VI)-induced p53 activation. Am. J. Physiol. Cell Physiol. 279, C868-C875 (2000)
12. Das UN. Tuning free radical metabolism to kill tumor cells selectively with emphasis on the interaction(s) between essential fatty acids, free radicals, lymphokines and prostaglandins. Ind. J. Pathol. Microbiol. 33, 94-103 (1990)
13. Das UN. Cis-unsaturated fatty acids as potential anti-mutagenic, tumoricidal and anti-metastatic agents. Asia Paci. J. Pharmacol. 7, 305-327 (1992) (Pubitemid 23044518)
14. Galeotti T, Borrello S, Masoti L. Oxy radical sources, scavenger systems and membrane damage in cancer cells. In:Oxygen Radicals, Systemic Events and Disease Processes. Das DK, Essman R (Eds). S Karger, Basel, Switzerland, 129-148 (1990)
15. Dianzani MU, Rossi MA. Lipid peroxidation in tumors. In:Recent Trends in Chemical Carcinogenesis (Volume 1). Pani P, Feo F, Columbano A, Cagliari ESA (Eds). Cagliari, Italy, 243-257 (1981)
16. Bartoli GM, Galeotti T. Growth-related lipid peroxidation in tumor microsomal membranes and mitochondria. Biochim. Biophys. Acta 574, 537-541 (1979) (Pubitemid 10226479)
17. Hostetler KY, Zenner BD, Morris HP. Phospholipid content of mitochondrial and microsomal membranes from Morris hepatomas of varying growth rates. Cancer Res. 39, 2978-2983 (1979) (Pubitemid 9226905)
18. Hartz JW, Morton RE, Waite MM, Morris HP. Correlation of fatty acyl composition of mitochondrial and microsomal phospholipid with growth rate of rat hepatomas. Lab. Invest. 46, 73-78 (1982) (Pubitemid 12167018)
19. Cheeseman KH, Emery S, Maddix SP, Slater TF, Burton GW, Ingold K. Studies on lipid peroxidation in normal and tumour tissue. The Yoshida rat liver tumour. Biochem. J. 250, 247-252 (1988) (Pubitemid 18060785)
20. Cheeseman KH, Burton GW, Ingold KU, Slater TF. Lipid peroxidation and lipid antioxidants in normal and tumor cells. Toxicol. Pathol. 12, 235-239 (1984) (Pubitemid 15175920)
21. Borrello S, Minotti G, Galeotti T. Factors influencing O2 and t-Bu OOH-dependent lipid peroxidation of tumor microsomes. In:Superoxide and Superoxide Dismutase in Chemistry, Biology and Medicine . Rotilio G (Ed.). Elsevier,Amsterdam, The Netherlands, 323-324 (1988)
22. Das UN, Begin ME, Ells G, Huang YS, Horrobin DF. Polyunsaturated fatty acids augment free radical generation in tumor cells in vitro. Biochem. Biophys. Res. Comm. 145, 15-24 (1987) (Pubitemid 17088399)
23. Das UN, Huang YS, Begin ME, Ells G, Horrobin DF. Uptake and distribution of cis-unsaturated fatty acids and their effect on free radical generation in normal and tumor cells in vitro. Free Rad. Biol. Med. 3, 9-14 (1987)
24. Bendetti A. Loss of lipid peroxidation as a histochemical marker for preneoplastic hepatocellular foci of rats. Cancer Res. 44, 5712-5717 (1984)
25. Dunbar LM, Bailey JM. Enzyme deletions and essential fatty acid metabolism in cultured cells. J. Biol. Chem. 250, 1152-1153 (1975)
26. Morton RE, Hartz JW, Reitz RC, Waite BM, Morris H. The acyl-CoA desaturases of microsomes from rat liver and the Morris 7777 hepatoma. Biochim. Biophys. Acta 573, 321-331 (1979) (Pubitemid 9175712)
27. Nassar BA, Das UN, Huang YS, Ells G, Horrobin DF. The effect of chemical hepatocarcinogenesis on liver phospholipid composition in rats fed n-6 and n-3 fatty acid-supplemented diets. Proc. Soc. Exp. Biol. Med. 199, 365-368 (1992)
28. Das UN. Essential fatty acids - a review. Curr. Pharma. Biotechnol. 7, 467-482 (2006) (Pubitemid 46017539)
29. Das UN. Essential fatty acids, biochemistry, physiology, and pathology. Biotechnol. J. 1, 420-439 (2006)
30. Serhan CN, Arita M, Hong S, Gotlinger K. Resolvins, docosatrienes, and neuroprotectins, novel w-3-derived mediators, and their endogenous aspirin-triggered epimers. Lipids 39, 1125-1132 (2004) (Pubitemid 40129055)
31. Serhan CN, Hong S, Gronert K, et al. Resolvins, a family of bioactive products of w-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 196, 1025-1037 (2002) (Pubitemid 35231761)
32. Serhan CN, Clish CB, Brannon J, Colgan SP, Chiang N, Gronert K. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from w-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J. Exp. Med. 192, 1197-1204 (2000)
33. Serhan CN, Takano T, Chiang N, Gronert K, Clish CB. Formation of endogenous "antiinflammatory" lipid mediators by transcellular biosynthesis. Lipoxins and aspirin-triggered lipoxins inhibit neutrophil recruitment and vascular permeability. Am. J. Respir. Crit. Care Med. 161(2 Pt 2), S95-S101 (2000) (Pubitemid 30129424)
34. Cummings KB, Robertson RP. Prostaglandin, increased production by renal cell carcinoma. J. Urol. 118, 720-723 (1977) (Pubitemid 8242656)
35. Hong SL, Wheless CM, Levine L. Elevated prostaglandins synthetase activity in methylcholanthrene-transformed mouse BALB/3T3. Prostaglandins 13, 271-279 (1977) (Pubitemid 8049083)
36. Ylikorkala O, Kauppila A, Viinikka L. Effect of cytostatics on prostaglandin F2 a prostacyclin, and thromboxane in patients with gynecologic malignancies. Obstet. Gynecol. 58, 483-486 (1981) (Pubitemid 12232158)
37. Rolland PH, Martin PM, Jacquemier J, Rolland AM, Toga M. Prostaglandin in human breast cancer, evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells. J. Natl Cancer Inst. 64, 1061-1070 (1980) (Pubitemid 10100318)
38. Trevisani A, Ferretti E, Capuzzo A, Tomasi V. Elevated levels of prostaglandin E2 in Yoshida hepatoma and the inhibition of tumour growth by non-steroidal anti-inflammatory drugs. Br. J. Cancer 41, 341-347 (1980) (Pubitemid 10131238)
39. Young MR, Newby M. Enhancement of Lewis lung carcinoma cell migration by prostaglandin E2 produced by macrophages. Cancer Res. 46, 160-164 (1986) (Pubitemid 16189046)
40. Cyran J, Lea MA, Lysz TW. Prostaglandin biosynthetic capacity of hepatomas with different growth rates. Int. J. Biochem. 21, 445-451 (1989) (Pubitemid 19122035)
41. LeFever A, Funahashi A. Elevated prostaglandin E2 levels in bronchoalveolar lavage fluid of patients with bronchogenic carcinoma. Chest 98, 1397-1402 (1990)
42. Baxevanis CN, Reclos GJ, Gritzapis AD, Dedousis GV, Missitzis I, Papamichail M. Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer. Cancer 72, 491-501 (1993) (Pubitemid 23193457)
43. Qiao L, Kozoni V, Tsioulias GJ, et al. Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo. Biochim. Biophys. Acta 1258, 215-223 (1995)
44. Hansen-Petrik MB, McEntee MF, Jull B, Shi H, Zemel MB, Whelan J. Prostaglandin E(2) protects intestinal tumors from nonsteroidal anti-inflammatory drug-induced regression in Apc(Min/+) mice. Cancer Res. 62, 403-408 (2002) (Pubitemid 34106412)
45. Oberley L W, Buettner G. Role of SOD in cancer. A review. Cancer Res. 39, 1141-1149 (1979)
46. Tisdale MJ, Mahmoud MD. Activities of free radical metabolizing enzymes in tumours. Br. J. Cancer 47, 809-812 (1983) (Pubitemid 13053511)
47. Bize IB, Oberley LW, Morris HP. Superoxide dismutase and superoxide radical in Morris hepatomas. Cancer Res. 40, 3686-3693 (1980) (Pubitemid 10003772)
48. Hendrickse CW, Kelly RW, Radley S, Donovan IA, Keighley MR, Neoptolemos JP. Lipid peroxidation and prostaglandins in colorectal cancer. Br. J. Surg. 81, 1219-1223 (1994) (Pubitemid 24262965)
49. Mund RC, Pizato N, Bonatto S, et al. Decreased tumor growth in Walker 256 tumor-bearing rats chronically supplemented with fish oil involves COX-2 and PGE2 reduction associated with apoptosis and increased peroxidation. Prostaglandins Leukot Essent. Fatty Acids 76, 113-120 (2007) (Pubitemid 46217230)
50. Jang YC, Remmen VH. The mitochondrial theory of aging, insight from transgenic and knockout mouse models. Exp. Gerontol. 44, 256-260 (2009)
51. Gorman A, McGowan A, Cotter TG. Role of peroxide and superoxide anion during tumour cell apoptosis. FEBS Lett. 404, 27-33 (1997) (Pubitemid 27107801)
52. Li M, Beg AA. Induction of necrotic-like cell death by tumor necrosis factor a and caspase inhibitors, novel mechanism for killing virus-infected cells. J. Virol. 74, 7470-7477 (2000) (Pubitemid 30613092)
53. Huang TT, Carlson EJ, Raineri I, Gillespie AM, Kozy H, Epstein CJ. The use of transgenic and mutant mice to study oxygen free radical metabolism. Ann. NY Acad. Sci. 893, 95-112 (1999) (Pubitemid 30038070)
54. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine (3rd Edition). Oxford University Press, UK (1999)
55. Panaretakis T, Shabalina IG, Grandér D, Shoshan MC, DePierre JW. Reactive oxygen species and mitochondria mediate the induction of apoptosis in human hepatoma HepG2 cells by the rodent peroxisome proliferator and hepatocarcinogen, perfluorooctanoic acid. Toxicol. Appl. Pharmacol.173, 56-64 (2001) (Pubitemid 32480365)
56. Hampton MB, Fadeel B, Orrenius S. Redox regulation of the caspases during apoptosis. Ann. NY Acad. Sci. 854, 328-335 (1998) (Pubitemid 29022813)
57. Jacobson MD, Raff MC. Programmed cell death and Bcl-2 protection in very low oxygen. Nature 374, 814-816 (1995)
58. Pervaiz S, Ramalingam JK, Hirpara JL, Clément MV. Superoxide anion inhibits drug-induced tumor cell death. FEBS Lett. 459, 343-348 (1999) (Pubitemid 29467365)
59. Wagner BA, Buettner GR, Oberley LW, Burns CP. Sensitivity of K562 and HL-60 cells to edelfosine, an ether lipid drug, correlates with production of reactive oxygen species. Cancer Res. 58, 2809-2816 (1998) (Pubitemid 28311912)
60. Hampton MB, Fadeel B, Orrenius S. Redox regulation of the caspases during apoptosis. Ann. NY Acad. Sci. 854,328-335 (1998) (Pubitemid 29022813)
61. Arakaki N, Kajihara T, Arakaki R. Involvement of oxidative stress in tumor cytotoxic activity of hepatocyte growth factor/scatter factor. J. Biol. Chem. 274, 13541-13546 (1999)
62. Tamatani M, Ogawa S, Nuñez G, Tohyama M. Growth factors prevent changes in Bcl-2 and Bax expression and neuronal apoptosis induced by nitric oxide. Cell Death Differ. 5, 911-919 (1998) (Pubitemid 28484402)
63. Sattler M, Winkler T, Verma S. Hematopoietic growth factors signal through the formation of reactive oxygen species. Blood 93, 2928-2935 (1999) (Pubitemid 29200783)
64. Zimmerman RJ, Marafino BJ Jr, Chan A, Landre P, Winkelhake JL. The role of oxidant injury in tumor cell sensitivity to recombinant human tumor necrosis factor in vivo. Implications for mechanisms of action. J. Immunol. 142, 1405-1409 (1989) (Pubitemid 19067518)
65. Godfrey RW, Johnson WJ, Hoffstein ST. Recombinant tumor necrosis factor and interleukin-1 both stimulate human synovial cell arachidonic acid release and phospholipid metabolism. Biochem. Biophys. Res. Commun. 142, 235-241 (1987) (Pubitemid 17000779)
66. Dayer JM, Beutler B, Cerami A. Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J. Exp. Med. 162, 2163-2168 (1985) (Pubitemid 16149701)
67. Nara K, Odagiri H, Fujii M. Increased production of tumor necrosis factor and prostaglandin E2 by monocytes in cancer patients and its unique modulation by their plasma. Cancer Immunol. Immunother. 25, 126-132 (1987)
68. Neale ML, Fiera RA, Matthews N. Involvement of phospholipase A2 activation in tumour cell killing by tumour necrosis factor. Immunology 64, 81-85 (1988)
69. Hepburn A, Boeynaems JM, Fiers W, Dumont JE. Modulation of tumor necrosis factor- a cytotoxicity in L929 cells by bacterial toxins, hydrocortisone and inhibitors of arachidonic acid metabolism. Biochem. Biophys. Res. Commun. 149, 815-822 (1987) (Pubitemid 18023051)
70. Suffys P, Beyaert R, Van Roy F, Fiers W. Reduced tumour necrosis factor-induced cytotoxicity by inhibitors of the arachidonic acid metabolism. Biochem. Biophys. Res. Commun. 149, 735-743 (1987) (Pubitemid 18023041)
71. Matthews N, Neale ML, Jackson SK, Stark JM. Tumour cell killing by tumour necrosis factor, inhibition by anaerobic conditions, free-radical scavengers and inhibitors of arachidonate metabolism. Immunology 62, 153-155 (1987) (Pubitemid 17141392)
72. Berkow RL, Wang D, Larrick JW, Dodson RW, Howard TH. Enhancement of neutrophil superoxide production by preincubation with recombinant human tumor necrosis factor. J. Immunol. 139, 3783-3791 (1987) (Pubitemid 18013658)
73. Talmadge JE, Bowersox O, Tribble H, Lee SH, Shepard HM, Liggitt D. Toxicity of tumor necrosis factor is synergistic with g-interferon and can be reduced with cyclooxygenase inhibitors. Am. J. Pathol. 128, 410-425 (1987) (Pubitemid 17139893)
74. Hori T, Kashiyama S, Hayakawa M, et al. Tumor necrosis factor is cytotoxic to human fibroblasts in the presence of exogenous arachidonic acid. Exp. Cell Res. 185, 41-49 (1989) (Pubitemid 19284495)
75. Hayakawa M, Oku N, Takagi T, et al. Involvement of prostaglandin- producing pathway in the cytotoxic action of tumor necrosis factor. Cell Struct. Funct. 16, 333-340 (1991)
76. Das UN, Padma M, Sagar PS, Ramesh G, Koratkar R. Stimulation of free radical generation in human leukocytes by various agents including tumor necrosis factor is a calmodulin dependent process. Biochem. Biophys. Res. Commun. 167, 1030-1036 (1990) (Pubitemid 20113284)
77. Palombella VJ, Vilcek J. Mitogenic and cytotoxic actions of tumor necrosis factor in BALB/c 3T3 cells. Role of phospholipase activation. J. Biol.Chem. 264, 18128-18136 (1989) (Pubitemid 19279283)
78. Reid T, Ramesha CS, Ringold GM. Resistance to killing by tumor necrosis factor in an adipocyte cell line caused by a defect in arachidonic acid biosynthesis. J. Biol. Chem. 266, 16580-16586 (1991) (Pubitemid 21907838)
79. Chang DJ, Ringold GM, Heller RA. Cell killing and induction of manganous superoxide dismutase by tumor necrosis factor- a is mediated by lipoxygenase metabolites of arachidonic acid. Biochem. Biophys. Res. Commun. 188, 538-546 (1992)
80. Fletcher JR, Collins JN, Graves ED 3rd, et al. Tumor necrosis factor-induced mortality is reversed with cyclooxygenase inhibition. Ann. Surg. 217, 668-674 (1993)
81. Hayakawa M, Ishida N, Takeuchi K, et al. Arachidonic acid-selective cytosolic phospholipase A2 is crucial in the cytotoxic action of tumor necrosis factor. J. Biol. Chem. 268, 11290-11295 (1993) (Pubitemid 23162324)
82. West M, Mhatre M, Ceballos A, et al. The arachidonic acid 5-lipoxygenase inhibitor nordihydroguaiaretic acid inhibits tumor necrosis factor a activation of microglia and extends survival of G93A-SOD1 transgenic mice. J. Neurochem. 91, 133-143 (2004) (Pubitemid 39314944)
83. Kovar-ková M, Hofmanová J, Soucek K, Kozub'k A. The effects of TNF-a and inhibitors of arachidonic acid metabolism on human colon HT-29 cells depend on differentiation status. Differentiation 72, 23-31 (2004) (Pubitemid 41701528)
84. Vento R, D'Alessandro N, Giuliano M, Lauricella M, Carabillo M, Tesoriere G. Induction of apoptosis by arachidonic acid in human retinoblastoma Y79 cells, involvement of oxidative stress. Exp. Eye Res. 70, 503-517 (2000) (Pubitemid 30658892)
85. Sagar PS, Das UN. Cytotoxic action of cis-unsaturated fatty acids on human cervical carcinoma (HeLa) cells in vitro. Prostaglandins Leukot Essent. Fatty Acids 53, 287-299 (1995)
86. Das UN. Tumoricidal action of cis-unsaturated fatty acids and their relationship to free radicals and lipid peroxidation. Cancer Lett. 56, 235-243 (1991)
87. Lin PS, Kwock L, Goodchild NT. Copper chelator enhancement of bleomycin cytotoxicity. Cancer 46, 2360-2364 (1980) (Pubitemid 11253691)
88. Werts ED, Gould MN. Relationships between cellular superoxide dismutase and susceptibility to chemically induced cancer in the rat mammary gland. Carcinogenesis 7, 1197-1201 (1986) (Pubitemid 17123010)
89. Cameron DJ. Suppression or enhancement by superoxide dismutase of tumor cell killing by macrophages of normal donors and breast cancer patients. Jpn. J. Exp. Med. 56, 135-140 (1986) (Pubitemid 17171985)
90. Kawaguchi T, Takeyasu A, Matsunobu K, et al. Stimulation of Mn-superoxide dismutase expression by tumor necrosis factor- a, quantitative determination of Mn-SOD protein levels in TNF-resistant and sensitive cells by ELISA. Biochem. Biophys. Res. Commun. 171, 1378-1386 (1990) (Pubitemid 20318104)
91. Cervantes A, Pinedo HM, Lankelma J, Schuurhuis GJ. The role of oxygen-derived free radicals in the cytotoxicity of doxorubicin in multidrug resistant and sensitive human ovarian cancer cells. Cancer Lett. 41, 169-177 (1988)
92. Mimnaugh EG, Dusre L, Atwell J, Myers CE. Differential oxygen radical susceptibility of adriamycin-sensitive and -resistant MCF-7 human breast tumor cells. Cancer Res. 49, 8-15 (1989) (Pubitemid 19024400)
93. Huang C, Wu M. Superoxide dismutase activity in tissues from 19 cases of hepatocellular carcinoma. Zhonghua Yi Xue Za Zhi 70, 138-139 (1990)
94. Han YH, Kim SH, Kim SZ, Park WH. Antimycin A as a mitochondrial electron transport inhibitor prevents the growth of human lung cancer A549 cells. Oncol. Rep. 20, 689-693 (2008)
95. Malafa M, Margenthaler J, Webb B, Neitzel L, Christophersen M. Mn-SOD expression is increased in metastatic gastric cancer. J. Surg. Res. 88, 130-134 (2000) (Pubitemid 30085842)
96. Westman NG, Marklund SL. Copper-and zinc-containing superoxide dismutase and manganese-containing superoxide dismutase in human tissues and human malignant tumors. Cancer Res. 41, 2962-2966 (1981) (Pubitemid 11071842)
97. Zhong W, Oberley LW, Oberley TD, St Clair DK. Suppression of the malignant phenotype of human glioma cells by overexpression of manganese superoxide dismutase. Oncogene 14, 481-490 (1997) (Pubitemid 27087111)
98. Toh Y, Kuninaka S, Oshiro T, et al. Overexpression of manganese superoxide dismutase mRNA may correlate with aggressiveness in gastric and colorectal adenocarcinomas. Int. J. Oncol. 17, 107-112 (2000)
99. Izutani R, Asano S, Imano M, Kuroda D, Kato M, Ohyanagi H. Expression of manganese superoxide dismutase in esophageal and gastric cancers. J. Gastroenterol. 33, 816-822 (1998) (Pubitemid 29271542)
100. Zhong W, Yan T, Lim R, Oberley LW. Expression of superoxide dismutases, catalase, and glutathione peroxidase in glioma cells. Free Rad. Biol. Med. 27, 1334-1345 (1999) (Pubitemid 30001496)
101. Huang Y, He T, Domann FE. Decreased expression of manganese superoxide dismutase in transformed cells is associated with increased cytosine methylation of the SOD2 gene. DNA Cell Biol. 18, 643-652 (1999) (Pubitemid 29387801)
102. Clement MV, Pervaiz S. Reactive oxygen intermediates regulate cellular apoptosis response to apoptotic stimuli, an hypothesis. Free Rad. Biol. Med. 30, 247-252 (1999) (Pubitemid 29213163)
103. Saunders JA, Rogers LC, Klomsiri C, Poole LB, Daniel LW. Reactive oxygen species mediate lysophosphatidic acid induced signaling in ovarian cancer cells. Free Radic. Biol. Med. 49, 2058-2067 (2010)
104. Li M, Zhao L, Liu J, et al. Multi-mechanisms are involved in reactive oxygen species regulation of mTORC1 signaling. Cell Signal. 22, 1469-1476 (2010)
105. Morisaki N, Lindsey JA, Stitts JM, Zhang H, Cornwell DG. Fatty acid metabolism and cell proliferation. V. Evaluation of pathways for the generation of lipid peroxides. Lipids 19, 381-394 (1984) (Pubitemid 14062190)
106. Morisaki N, Sprecher H, Milo GE, Cornwell DG. Fatty acid specificity in the inhibition of cell proliferation and its relationship to lipid peroxidation and prostaglandin biosynthesis. Lipids 17, 893-899 (1982) (Pubitemid 13141029)
107. Liepkalns VA, Icard-Liepkalns C, Cornwell DG. Regulation of cell division in a human glioma cell clone by arachidonic acid and a-tocopherol quinone. Cancer Lett. 15, 173-178 (1982) (Pubitemid 12140572)
108. Cheeseman KH, Collins M, Maddix S, et al. Lipid peroxidation in regenerating rat liver. FEBS Lett. 209, 191-196 (1986) (Pubitemid 17234207)
109. Slater TF, Cheeseman KH, Benedetto C, et al. Studies on the hyperplasia ('regeneration') of the rat liver following partial hepatectomy. Changes in lipid peroxidation and general biochemical aspects. Biochem. J. 265, 51-59 (1990) (Pubitemid 20037673)
110. Kastan MB, Canman CE, Leonard CJ. P53, cell cycle control and apoptosis, implications for cancer. Cancer Metastasis Rev. 14, 3-15 (1995)
111. Martinez JD, Pennington ME, Craven MT, Warters RL, Cress AE. Free radicals generated by ionizing radiation signal nuclear translocation of p53. Cell Growth Differ. 8, 941-949 (1997) (Pubitemid 27388091)
112. Uberti D, Yavin E, Gil S, Ayasola KR, Goldfinger N, Rotter V. Hydrogen peroxide induces nuclear translocation of p53 and apoptosis in cells of oligodendroglia origin. Brain Res. Mol. Brain Res. 65, 167-175 (1999) (Pubitemid 29113266)
113. Kitamura Y, Ota T, Matsuoka Y, et al. Hydrogen peroxide-induced apoptosis mediated by p53 protein in glial cells. Glia. 25, 154-164 (1999) (Pubitemid 29032771)
114. Pani G, Bedogni B, Anzevino R, et al. Deregulated manganese superoxide dismutase expression and resistance to oxidative injury in p53-deficient cells. Cancer Res. 60, 4654-4660 (2000) (Pubitemid 32106655)
115. Hilf R, Murant RS, Narayana U, Gibson SL. Relationship of mitochondrial function and cellular adensine triphosphate levels to hematoporphyrin derivative-induced photosensitization in R 3230 AC mammary tumors. Cancer Res. 46, 211-217 (1986) (Pubitemid 16189053)
116. Lee Y, Shacter E. Hydrogen peroxide inhibits activation, not activity, of cellular caspase-3 in vivo. Free Radic. Biol. Med. 29, 684-692 (2000)
117. Saretzki G, von Zglinicki T. Replicative senescence as a model of aging, the role of oxidative stress and telomere shortening-an overview. Z. Gerontol. Geriatr. 32, 69-75 (1999) (Pubitemid 29230157)
118. Oikawa S, Kawanishi S. Site-specific DNA damage at GGG sequence by oxidative stress may accelerate telomere shortening. FEBS Lett. 453, 365-368 (1999) (Pubitemid 29326680)
119. von Zglinicki T, Pilger R, Sitte N. Accumulation of single-strand breaks is the major cause of telomere shortening in human fibroblasts. Free Radic. Biol. Med. 28, 64-74 (2000) (Pubitemid 30045574)
120. Tyurina YY, Tyurina VA, Certa G, Quinn PJ, Schor NF, Kagan VE. Direct evidence for antioxidant effect of BCL-2 in PC 12 rat pheochromocytoma cells. Arch. Biochem. Biophys. 344, 413-423 (1997) (Pubitemid 27344079)
121. Haldar S, Negrini M, Monne M, Sabbioni S, Croce CM. Down regulation of bcl-2 by p53 in breast cancer cells. Cancer Res. 54, 2095-2097 (1994) (Pubitemid 24138678)
122. Haldar S, Jena N, Croce CM. Inactivation of Bcl-2 by phosphorylation. Proc. Natl Acad. Sci. USA 92, 4507-4511 (1995)
123. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75, 241-251 (1993) (Pubitemid 23320288)
124. Das UN. Essential fatty acids, lipid peroxidation and apoptosis. Prostaglandins Leukotrienes Essen. Fatty Acids 61, 157-163 (1999) (Pubitemid 29520805)
125. Padma M, Das UN. Effect of cis-unsaturated fatty acids on the activity of protein kinases and protein phosphorylation in macrophage tumor (AK-5) cells in vitro. Prostaglandins Leukotrienes Essen. Fatty Acids 60, 55-63 (1999) (Pubitemid 29182166)
126. Esposti MD, Hatzinisiriou I, McLennan H, Ralph S. Bcl-2 and mitochondrial oxygen radicals. New approaches with reactive oxygen species-sensitive probes. J. Biol. Chem. 274, 29831-29837 (1999)
127. Lin HL, Liu TY, Chau GY, Lui WY, Chi CW. Comparison of 2-methoxyestradiol-induced, docetaxel-induced, and paclitaxel-induced apoptosis in hepatoma cells and its correlation with reactive oxygen species. Cancer 89, 983-994 (2000)
128. Huang P, Feng L, Oldham E A, Keating MJ, Plunkett W. Superoxide dismutase as a target for the selective killing of cancer cells. Nature 407, 390-395 (2000)
129. Das UN. A radical approach to cancer. Med. Sci. Monit. 8, RA79-RA92 (2002) (Pubitemid 34453440)
130. Ge Y, Byun JS, De Luca P, et al. Combinatorial antileukemic disruption of oxidative homeostasis and mitochondrial stability by the redox reactive thalidomide 2-(2,4-difluoro-phenyl)-4,5,6,7-tetrafluoro-1H-isoindole- 1,3(2H)-dione (CPS49) and flavopiridol. Mol. Pharmacol. 74, 872-883 (2008)
131. Colquhoun A. Mechanisms of action of eicosapentaenoic acid in bladder cancer cells in vitro, alterations in mitochondrial metabolism, reactive oxygen species generation and apoptosis induction. J. Urol. 181, 1885-1893 (2009)
132. Naidu MR, Das UN, Kishan A. Intratumoral g-linoleic acid therapy of human gliomas. Prostaglandins Leukot. Essent. Fatty Acids 45, 181-184 (1992)
133. Das UN, Prasad VV, Reddy DR. Local application of g-linolenic acid in the treatment of human gliomas. Cancer Lett. 94, 147-155 (1995)
134. Bakshi A, Mukherjee D, Bakshi A, Banerji AK, Das UN. g-linolenic acid therapy of human gliomas. Nutrition 19, 305-309 (2003) (Pubitemid 36390122)
135. Das UN. g-linolenic acid therapy of human glioma-a review of in vitro, in vivo, and clinical studies. Med. Sci. Monit. 13, RA119-RA31 (2007)
136. Reddy DR, Prasad VS, Das UN. Intratumoural injection of g linolenic acid in malignant gliomas. J. Clin. Neurosci. 5, 36-39 (1998) (Pubitemid 128646482)
137. Smith DL, Willis AL, Mahmud I. Eicosanoid effects on cell proliferation in vitro, relevance to atherosclerosis. Prostaglandins Leukotrienes Med. 16, 1-10 (1984) (Pubitemid 14012719)
138. Sakai T, Yamaguchi N, Shiroko Y, Sekiguchi M, Fujii G, Nishino H. Prostaglandin D2 inhibits the proliferation of human malignant tumor cells. Prostaglandins 27, 17-26 (1984) (Pubitemid 14160159)
139. Booyens J, Englebrecht P, Le Roux S, Louwrens CC, Van der Merwe CF, Katzeff IE. Some effects of the essential fatty acids linoleic acid, a-linolenic acid, and of their metabolites g-linolenic acid, arachidonic acid, eicosapentaenoic acid, and docosahexaenoic acid and of prostaglandins A and E on the proliferation of human osteogenic sarcoma cells in culture. Prostaglandins Leukotrienes Med. 15, 15-33 (1984) (Pubitemid 14083130)
140. Begin ME, Das UN, Ells G, Horrobin DF. Selective killing of human cancer cells by polyunsaturated fatty acids. Prostaglandins Leukotrienes Med. 19, 177-186 (1985) (Pubitemid 15018984)
141. Begin ME, Ells G, Das UN, Horrobin DF. Differential killing of human carcinoma cells supplemented with n-3 and n-6 polyunsaturated fatty acids. J. Natl Cancer Inst. 77, 1053-1062 (1986) (Pubitemid 17184127)
142. Das UN. Tumoricidal action of cis-unsaturated fatty acids and their relationship to free radicals and lipid peroxidation. Cancer Lett. 56, 235-243 (1991)
143. Sagar PS, Das UN, Koratkar R, Ramesh G, Padma M, Kumar GS. Cytotoxic action of cis-unsaturated fatty acids on human cervical carcinoma (HeLa) cells, relationship to free radicals and lipid peroxidation and its modulation by calmodulin antagonists. Cancer Lett. 63, 189-198 (1992)
144. Kumar GS, Das UN. Free radical-dependent suppression of growth of mouse myeloma cells by a-linolenic and eicosapentaenoic acids in vitro. Cancer Lett. 92, 27-38 (1995)
145. Padma M, Das UN. Effect of cis-unsaturated fatty acids on cellular oxidant stress in macrophage tumor (AK-5) cells in vitro. Cancer Lett. 109, 63-75 (1996) (Pubitemid 27026205)
146. Seigel I, Liu TL, Yaghoubzadeh E, Kaskey TS, Gleicher N. Cytotoxic effects of free fatty acids on ascites tumor cells. J. Natl Cancer Inst. 78, 271-277 (1987) (Pubitemid 17027743)
147. Tolnai S, Morgan JF. Studies on the in vitro anti-tumor activity of fatty acids. V. Unsaturated fatty acids. Can. J. Biochem. Physiol. 40, 869-875 (1962)
148. Rossi MA, Cecchini G. Lipid peroxidation in hepatomas of different degrees of deviation. Cell Biochem. Function 1, 49-54 (1983) (Pubitemid 13044213)
149. Burlakova EB, Palmina NP. On the possible role of free radical mechanism on the regulation of cell replication. Biofizika 12, 82-88 (1967)
150. Gonzalez M, Schemmel R, Dugan L, Gray J, Welsch C. Dietary fish oil inhibits human breast carcinoma growth, A function of increased lipid peroxidation. Lipids 28, 827-832 (1993) (Pubitemid 23277647)
151. Cao Y, Pearman AT, Zimmerman GA, McIntyre TM, Prescott SM. Intracellular unesterified arachidonic acid signals apoptosis. Proc. Natl Acad. Sci. USA 97, 11280-11285 (2000)
152. Brekke OL, Sagen E, Bjerve KS. Specificity of endogenous fatty acid release during tumor necrosis factor-induced apoptosis in WEHI 164 fibrosarcoma cells. J. Lipid Res. 40, 2223-2233 (1999) (Pubitemid 30017524)
153. Ramesh G, Das UN. Effect of free fatty acids on two stage skin carcinogenesis in mice. Cancer Lett. 100, 199-209 (1996) (Pubitemid 26053945)
154. Calviello G, Palozza O, Piccioni E, et al. Supplementation with eicosapentaenoic and docosahexaenoic acid inhibits growth of Morris hepatocarcinoma 3924A in rats, Effects on proliferation and apoptosis. Int. J. Cancer 75, 699-705 (1998) (Pubitemid 28145816)
155. Chapkin RS, Jiang YH, Davidson LA, Lupton JR. Modulation of intracellular second messengers by dietary fat during colonic tumor development. Adv. Exp. Med. Biol. 422, 85-96 (1997) (Pubitemid 27479175)
156. Collett ED, Davidson LA, Fan Y-Y, Lupton JR, Chapkin RS. n-6 and n-3 polyunsaturated fatty acids differentially modulate oncogenic Ras activation in colonocytes. Am. J. Physiol. Cell Physiol. 280, C1066-C1075 (2001)
157. Roynette CE, Calder PC, Dupertuis YM, Pichar C. n-3 Polyunsaturated fatty acids and colon cancer prevention. Clin. Nutr. 23, 139-151 (2004) (Pubitemid 38401208)
158. Calviello G, Di Nicuolo F, Gragnoli S, et al. n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2induced ERK-1 and -2 and HIF-1a induction pathway. Carcinogenesis 25, 2303-2310 (2004) (Pubitemid 39625169)
159. Cai J, Jiang WG, Mansel RE. Inhibition of angiogenic factor- and tumor-induced angiogenesis by g -linolenic acid. Prostaglandins Leukotrienes Essen. Fatty Acids 60, 21-29 (1999) (Pubitemid 29182162)
160. Rose DP, Connolly JM. Antiangiogenicity of docosahexaenoic acid and its role in the suppression of breast cancer cell growth in nude mice. Int. J. Oncol. 15, 1011-1015 (1999)
161. Jin Y, Arita M, Zhang Q, et al. Anti-angiogenesis Effect of the novel anti-inflammatory and pro-resolving lipid mediators. Invest. Ophthalmol. Vis. Sci.50, 4743-4752 (2009)
162. Schlager SI, Ohanian SH. Correlation between lipid synthesis in tumor cells and their sensitivity to humoral immune attack. Science 197, 773-776 (1977) (Pubitemid 8153402)
163. Schlager SI, Ohanian SH, Borsos T. Correlation between the ability of tumor cells to incorporate specific fatty acids and their sensitivity to killing by a specific antibody plus guinea pig complement. J. Natl Cancer Inst. 61, 931-934 (1978) (Pubitemid 9053292)
164. Schlager SI, Ohanian SH. Modulation of tumor cell susceptibility to humoral immune killing through chemical and physical manipulation of cellular lipid and fatty acid composition. J. Immunol. 125, 1196-1200 (1980) (Pubitemid 10048961)
165. Schlager SI, Madden LD, Meltzer MS, Bara S, Mamula MJ. Role of macrophage lipids in regulating tumoricidal activity. Cell Immunol. 77, 52-68 (1983) (Pubitemid 13135598)
166. Schlager SI, Meltzer MS, Madden LD. Role of membrane lipids in the immunological killing of tumor cells, II. Effector cell lipids. Lipids 18, 483-488 (1983)
167. Schlager SI, Ohanian SH. Role of membrane lipids in the immunological killing of tumor cells, I. Target cell lipids. Lipids 18, 475-482 (1983)
168. Schlager SI, Meltzer MS. Role of macrophage lipids in regulating tumoricidal activity. II. Internal genetic and external physiologic regulatory factors controlling macrophage tumor cytotoxicity also control characteristic lipid changes associated with tumoricidal cells. Cell Immunol. 80, 10-19 (1983) (Pubitemid 13050189)
169. Bell HS, Wharton SB, Leaver HA, Whittle IR. Effects of N-6 essential fatty acids on glioma invasion and growth, experimental studies with glioma spheroids in collagen gels. J. Neurosurg. 91, 989-996 (1999)
170. Leaver HA, Wharton SB, Bell HS, Leaver-Yap IM, Whittle IR. Highly unsaturated fatty acid induced tumour regression in glioma pharmacodynamics and bioavailability of g linolenic acid in an implantation glioma model, effects on tumour biomass, apoptosis and neuronal tissue histology. Prostaglandins Leukot. Essent. Fatty Acids 67, 283-292 (2002) (Pubitemid 35397368)
171. Benadiba M, Miyake JA, Colquhoun A. g-linolenic acid alters Ku80, E2F1, and bax expression and induces micronucleus formation in C6 glioma cells in vitro. IUBMB Life 61, 244-251 (2009)
172. Rohrbach S. Effects of dietary polyunsaturated fatty acids on mitochondria. Curr. Pharm. Des. 15, 4103-4116 (2009)
173. Tuo Y, Wang D, Li S, Chen C. Long-term exposure of INS-1 rat insulinoma cells to linoleic acid and glucose in vitro affects cell viability and function through mitochondrial-mediated pathways. Endocrine 39, 128-138 (2011)
174. Zeghichi-Hamri S, de Lorgeril M, Salen P, et al. Protective effect of dietary n-3 polyunsaturated fatty acids on myocardial resistance to ischemia-reperfusion injury in rats. Nutr. Res. 30, 849-857 (2010)
175. Hagopian K, Weber KL, Hwee DT, et al. Complex I-associated hydrogen peroxide production is decreased and electron transport chain enzyme activities are altered in n-3 enriched fat-1 mice. PLoS One 5, e12696 (2010)
176. Kansal S, Negi AK, Kaur R, et al. Evaluation of the role of oxidative stress in chemopreventive action of fish oil and celecoxib in the initiation phase of 7,12-dimethyl benz(a)anthracene-induced mammary carcinogenesis. Tumour. Biol. 32, 167-177 (2011)
177. Dymkowska D, Wojtczak L. Arachidonic acid-induced apoptosis in rat hepatoma AS-30D cells is mediated by reactive oxygen species. Acta Biochim. Pol. 56, 711-715 (2009)
178. Ribeiro G, Benadiba M, de Oliveira Silva D, Colquhoun A. The novel ruthenium-g-linolenic complex [Ru(2) (aGLA(4)Cl] inhibits C6 rat glioma cell proliferation and induces changes in mitochondrial membrane potential, increased reactive oxygen species generation and apoptosis in vitro. Cell Biochem. Funct. 8, 15-23 (2010)
179. Giros A, Grzybowski M, Sohn VR, et al. Regulation of colorectal cancer cell apoptosis by the n-3 polyunsaturated fatty acids docosahexaenoic and eicosapentaenoic. Cancer Prev. Re. (Phila) 2, 732-742 (2009)
180. Ponnala S, Rao KP, Chaudhury JR, et al. Effect of polyunsaturated fatty acids on diphenyl hydantoin-induced genetic damage in vitro and in vivo. Prostaglandins Leukot. Essent. Fatty Acids 80, 43-50 (2009)
181. Das UN, Rao KP. Effect of g-linolenic acid and prostaglandins E1 on g-radiation and chemical-induced genetic damage to the bone marrow cells of mice. Prostaglandins Leukot. Essent. Fatty Acids 74, 165-173 (2006) (Pubitemid 43363497)
182. Das UN, Ramadevi G, Rao KP, Rao MS. Prostaglandins and their precursors can modify genetic damage-induced by g-radiation and benzo(a)pyrene. Prostaglandins 29, 911-920 (1985)
183. Das UN. Tumoricidal and anti-angiogenic actions of g-linolenic acid and its derivatives. Curr. Pharm. Biotechnol. 7, 457-466 (2006) (Pubitemid 46017538)
184. Dhayal S, Morgan NG. Pharmacological characterization of the cytoprotective effects of polyunsaturated fatty acids in insulin-secreting BRIN-BD11 cells. Br. J. Pharmacol. 162, 1340-1350 (2011)
185. Bazan NG. w-3 fatty acids, pro-inflammatory signaling and neuroprotection. Curr. Opin. Clin. Nutr. Metab. Care 10, 136-141 (2007) (Pubitemid 46220304)
186. Suresh Y, Das UN. Long-chain polyunsaturated fatty acids and chemically induced diabetes mellitus, effect of w-6 fatty acids. Nutrition 19, 93-114 (2003) (Pubitemid 36194469)
187. Suresh Y, Das UN. Long-chain polyunsaturated fatty acids and chemically induced diabetes mellitus. Effect of w-3 fatty acids. Nutrition 19, 213-228 (2003) (Pubitemid 36279459)
188. Sangeetha PS, Das UN. g-linolenic acid and eicosapentaenoic acid potentiate the cytotoxicity of anti-cancer drugs on human cervical carcinoma (HeLa) cells in vitro. Med. Sci. Res. 21, 457-459 (1993) (Pubitemid 23187011)
189. Madhavi N, Das UN. Reversal of KB-3-1 and KB-Ch-8-5 tumor cell drug-resistance by cis-unsaturated fatty acids in vitro. Med. Sci. Res. 22, 689-692 (1994) (Pubitemid 24355348)
190. Madhavi N, Das UN. Effect of n-6 and n-3 fatty acids on the survival of vincristine sensitive and resistant human cervical carcinoma cells in vitro. Cancer Lett. 84, 31-41 (1994) (Pubitemid 24260280)
191. Das UN, Madhavi N, Sravan Kumar G, Padma M, Sangeetha P. Can tumour cell drug resistance be reversed by essential fatty acids and their metabolites? Prostaglandins Leukot. Essent. Fatty Acids 58, 39-54 (1998) (Pubitemid 28053789)
192. Germain E, Chaj's V, Cognault S, Lhuillery C, Bougnoux P. Enhancement of doxorubicin cytotoxicity by polyunsaturated fatty acids in the human breast tumor cell line MDA-MB-231, relationship to lipid peroxidation. Int. J. Cancer 75, 578-583 (1998) (Pubitemid 28094104)
193. Mahéo K, Vibet S, Steghens JP, et al. Differential sensitization of cancer cells to doxorubicin by DHA, a role for lipoperoxidation. Free Radic. Biol. Med. 39, 742-751 (2005) (Pubitemid 41139889)
194. Ilc K, Ferrero JM, Fischel JL, et al. Cytotoxic effects of two g-linoleic salts (lithium g-linolenate or meglumine g-linolenate) alone or associated with a nitrosourea, an experimental study on human glioblastoma cell lines. Anticancer Drugs 10, 413-417 (1999)
195. Menendez JA, Ropero S, Lupu R, Colomer R. w-6 polyunsaturated fatty acid g-linolenic acid (18,3n-6) enhances docetaxel (Taxotere) cytotoxicity in human breast carcinoma cells, Relationship to lipid peroxidation and HER-2/neu expression. Oncol. Rep. 11, 1241-1252 (2004)
196. Menéndez JA, Ropero S, del Barbacid MM, et al. Synergistic interaction between vinorelbine and g-linolenic acid in breast cancer cells. Breast Cancer Res. Treat. 72, 203-219 (2002) (Pubitemid 34430002)
197. Menendez JA, Ropero S, Mehmi I, Atlas E, Colomer R, Lupu R. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal a -linolenic and g-linolenic fatty acids, a novel mechanism by which dietary fat can alter mammary tumorigenesis. Int. J. Oncol. 24, 1369-1383 (2004)
198. Kong X, Ge H, Chen L, et al. g-linolenic acid modulates the response of multidrug-resistant K562 leukemic cells to anticancer drugs. Toxicol. In vitro 23, 634-639 (2009)
199. Ghosh J, Myers CE. Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells. Proc. Natl Acad. Sci. USA 95, 13182-13187 (1998) (Pubitemid 28509545)
200. Rizzo MT, Regazzi E, Garau D, et al. Induction of apoptosis by arachidonic acid in chronic myeloid leukemia cells. Cancer Res. 59, 5047-5053 (1999) (Pubitemid 29472914)
201. Wolf LA, Laster SM. Characterization of arachidonic acid-induced apoptosis. Cell. Biochem. Biophys. 30, 353-368 (1999) (Pubitemid 129548874)
202. Cao Y, Pearman AT, Zimmerman GA, McIntyre TM, Prescott SM. Intracellular unesterified arachidonic acid signals apoptosis. Proc. Natl Acad. Sci. USA 97, 11280-11285 (2000)
203. Cao Y, Dave KB, Doan TP, Prescott SM. Fatty acid CoA ligase 4 is upregulated in colon adenocarcinoma. Cancer Res. 61, 8429-8434 (2001) (Pubitemid 33131120)
204. Sun Y, Tang XM, Half E, Kuo MT, Sinicrope FA. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells. Cancer Res. 62, 6323-6328 (2002) (Pubitemid 35244488)
205. Tang X, Sun YJ, Half E, Kuo MT, Sinicrope F. Cyclooxygenase-2 overexpression inhibits death receptor 5 expression and confers resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human colon cancer cells. Cancer Res. 62, 4903-4908 (2002) (Pubitemid 34984412)
206. Shureiqi I, Chen D, Lotan R, et al. 15-lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells. Cancer Res. 60, 6846-6850 (2000) (Pubitemid 32059150)
207. Shureiqi I, Chen D, Lee JJ, et al. 15-LOX-1, a novel molecular target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells. J. Natl Cancer Inst. 92, 1136-1142 (2000)
208. Shureiqi I, Xu X, Chen D, et al. Nonsteroidal anti-inflammatory drugs induce apoptosis in esophageal cancer cells by restoring 15-lipoxygenase-1 expression. Cancer Res. 61, 4879-4884 (2001) (Pubitemid 32691905)
209. Maccarrone M, Ranalli M, Bellincampi L, et al. Activation of different lipoxygenase isozymes induces apoptosis in human erythroleukemia and neuroblastoma cells. Biochem. Biophys. Res. Commun. 272, 345-350 (2000) (Pubitemid 30444620)
210. Avis I, Hong SH, Martinez A, et al. Five-lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions. FASEB J. 15, 2007-2009 (2001)
211. Hong SH, Avis I, Vos MD, Martinez A, Treston AM, Mulshine JL. Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors. Cancer Res. 59, 2223-2228 (1999) (Pubitemid 29217689)
212. Leaver HA, Bell HS, Rizzo MT, et al. Antitumour and pro-apoptotic actions of highly unsaturated fatty acids in glioma. Prostaglandins Leukot. Essent. Fatty Acids 66, 19-29 (2002) (Pubitemid 34717685)
213. Menendez JA, Ropero S, Mehmi I, Atlas E, Colomer R, Lupu R. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal a-linolenic and g-linolenic fatty acids, a novel mechanism by which dietary fat can alter mammary tumorigenesis. Int. J. Oncol. 24, 1369-1383 (2004)
214. Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival, Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-k B. Int. J. Oncol. 24, 591-608 (2004)
215. Menendez JA, Colomer R, Lupu R. Inhibition of fatty acid synthase-dependent neoplastic lipogenesis as the mechanism of g-linolenic acid-induced toxicity to tumor cells, an extension to Nwankwo's hypothesis. Med. Hypotheses 64, 337-341 (2005) (Pubitemid 40028282)
216. Menendez JA, Colomer R, Lupu R. Why does tumor-associated fatty acid synthase (oncogenic antigen-519) ignore dietary fatty acids? Med. Hypotheses 64, 342-349 (2005) (Pubitemid 40028283)
217. Nomura DK, Long JZ, Niessen S, Hoover HS, Ng S-W, Cravatt BF. Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell 140, 49-61 (2010)
218. Levine L. Proteasome inhibitors, their effects on arachidonic acid release from cells in culture and arachidonic acid metabolism in rat liver cells. BMC Pharmacol. 4, 15. (2004)
219. Eitsuka T, Nakagawa K, Suzuki T, Miyazawa T. Polyunsaturated fatty acids inhibit telomerase activity in DLD-1 human colorectal adenocarcinoma cells, a dual mechanism approach. Biochim. Biophys. Acta 1737, 1-10 (2005) (Pubitemid 41550377)
220. Eitsuka T, Nakagawa K, Miyazawa T. Dual mechanisms for telomerase inhibition in DLD-1 human colorectal adenocarcinoma cells by polyunsaturated fatty acids. Biofactors 21, 19-21 (2004) (Pubitemid 40921820)
221. Jiang WG, Bryce RP, Mansel RE. g linolenic acid regulates gap junction communication in endothelial cells and their interaction with tumour cells. Prostaglandins Leukot. Essen. Fatty Acids 56, 307-316 (1997) (Pubitemid 27174409)
222. Sethi S, Eastman AY, Eaton JW. Inhibition of phagocyte-endothelium interactions by oxidized fatty acids, a natural anti-inflammatory mechanism? J. Lab. Clin. Med. 128, 27-38 (1996) (Pubitemid 26369168)
223. Germain E, Chajes V, Cognault S, Lhuillery C, Bougnoux P. Enhancement of doxorubicin cytotoxicity by polyunsaturated fatty acids in the human breast tumor cell line MDA-MB-231; relationship to lipid peroxidation. Int. J. Cancer 75, 578-583 (1998) (Pubitemid 28094104)
224. Shao Y, Pardini L, Pardini RS. Dietary menhaden oil enhances mitomycin C antitumor activity toward human mammary carcinoma MX-1. Lipids 30, 1035-1045 (1995)
225. Chow SC, Jondal M. Ca2+ entry in T cells is activated by emptying the inositol 1,4,5-triphosphate sensitive Ca2+ pool. Cell Calcium 11, 641-646 (1990)
226. Nakagawa T, Zhu H, Morishima N, et al. Caspase-12 mediates endoplasmic reticulum-specific apoptosis and cytotoxicity by amyloid-b. Nature 403, 98-103 (2000) (Pubitemid 30038529)
227. Huang ZH, Hii CS, Rathjen DA, Poulos A, Murray AW, Ferrante A. N-6 and N-3 polyunsaturated fatty acids stimulate translocation of protein kinase Ca, bI,bII and -e and enhance agonist-induced NADPH oxidase in macrophages. Biochem. J. 325 (pt 2), 553-557 (1997)
228. Peterson DA, Mehta N, Butterfield J, et al. Polyunsaturated fatty acids stimulate superoxide formation in tumor cells, a mechanism for specific cytotoxicity and a model for tumor necrosis factor? Biochem. Biophys. Res. Commun. 155, 1033-1037 (1988)
229. Chiu LC, Wan JM. Induction of apoptosis in HL-60 cells by eicosapentaenoic acid (EPA) is associated with downregulation of bcl-2 expression. Cancer Lett. 145, 17-27 (1999) (Pubitemid 29459065)
230. Albino AP, Juan G, Traganos F, et al. Cell cycle arrest and apoptosis of melanoma cells by docosahexaenoic acid, association with decreased pRb phosphorylation. Cancer Res. 60, 4139-4145 (2000) (Pubitemid 30636596)
231. Chen ZY, Istfan NW. Docosahexaenoic acid, a major constituent of fish oil diets, prevents activation of cyclin-dependent kinases and S-phase entry by serum stimulation in HT-29 cells. Prostaglandins Leukot. Essent. Fatty Acids 64, 67-73 (2001) (Pubitemid 32142558)
232. Palakurthi SS, Fluckiger R, Aktas H, et al. Inhibition of translation initiation mediates the anticancer effect of the n-3 polyunsaturated fatty acid eicosapentaenoic acid. Cancer Res. 60, 2919-2925 (2000) (Pubitemid 30395816)
233. Nishida M, Maruyama Y, Tanaka R, Kontani K, Nagao T, Kurose H. G ai and G ao are target proteins of reactive oxygen species. Nature 408, 492-495 (2000)
234. Das UN. Abrupt and complete occlusion of tumor-feeding vessels by g-linolenic acid. Nutrition 18, 662-664 (2002) (Pubitemid 34687110)
235. Das UN. Occlusion of infusion vessels on g-linolenic acid infusion. Prostaglandins Leukot. Essent. Fatty Acids 70; 23-32 (2004) (Pubitemid 38021638)
236. Calon F, Lim GP, Yang F, et al. Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron 43, 633-645 (2004) (Pubitemid 39179724)
237. Lukiw WJ, Cui J-G, Marcheselli VL, et al. A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J. Clin. Invest. 115, 2774-2783 (2005) (Pubitemid 41434404)
238. Comba A, Maestri DM, Berra MA, et al. Effect of w-3 and w-9 fatty acid rich oils on lipoxygenases and cyclooxygenases enzymes and on the growth of a mammary adenocarcinoma model. Lipids Health Dis. 9, 112 (2010)
239. Liu B, Maher RJ, Hannun YA, Porter AT, Honn KV. 12(S)-HETE enhancement of prostate tumor cell invasion, selective role of PKC a. J. Natl Cancer Inst. 86, 1145-1151 (1994) (Pubitemid 24249300)
240. Ding XZ, Tong WG, Adrian TE. 12-lipoxygenase metabolite 12(S)-HETE stimulates human pancreatic cancer cell proliferation via protein tyrosine phosphorylation and ERK activation. Int. J. Cancer 94, 630-636 (2001) (Pubitemid 33035681)
241. Chen GG, Xu H, Lee JF, et al. 15-hydroxy-eicosatetraenoic acid arrests growth of colorectal cancer cells via a peroxisome proliferator-activated receptor g-dependent pathway. Int. J. Cancer 107, 837-843 (2003) (Pubitemid 37339740)
242. Najid A, Beneytout JL, Tixier M. Cytotoxicity of arachidonic acid and of its lipoxygenase metabolite 15-hydroperoxyeicosatetraenoic acid on human breast cancer MCF-7 cells in culture. Cancer Lett. 46, 137-141 (1989) (Pubitemid 19189403)
243. Shureiqi I, Jiang W, Zuo X, et al. The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-d to induce apoptosis in colorectal cancer cells. Proc. Natl Acad. Sci. USA 100, 9968-9973 (2003) (Pubitemid 37087052)
244. Nixon JB, Kim KS, Lamb PW, Bottone FG, Eling TE. 15-lipoxygenase-1 has anti-tumorigenic effects in colorectal cancer. Prostaglandins Leukot. Essent. Fatty Acids 70, 7-15 (2004) (Pubitemid 38021636)
245. Kim SJ. Lipoxins formation by rat basophilic leukemia (RBL-1) cells. Res. Commun. Chem. Pathol. Pharmacol. 68, 159-174 (1990) (Pubitemid 20178446)
246. Stenke L, Edenius C, Samuelsson J, Lindgren JA. Deficient lipoxin synthesis, a novel platelet dysfunction in myeloproliferative disorders with special reference to blastic crisis of chronic myelogenous leukemia. Blood 78, 2989-2995 (1991)
247. Chen Y, Hao H, He S, et al. Lipoxin A4 and its analogue suppress the tumor growth of transplanted H22 in mice, the role of antiangiogenesis. Mol. Cancer Ther. 9, 2164-2174 (2010)
248. Gleissman H, Yang R, Martinod K, et al. Docosahexaenoic acid metabolome in neural tumors, identification of cytotoxic intermediates. FASEB J. 24, 906-915 (2010)
249. Wolrum C, Shi S, Jayaprakash KN, et al. Mechanisms and optimization of in vivo delivery of lipophilic siRNAs. Nat. Biotechnol. 25, 1149-1157 (2007) (Pubitemid 47538115)
250. Ichim TE, Popov IA, Riordan NH, et al. A novel method of modifying immune responses by vaccination with lipiodol-siRNA mixtures. J. Translat. Med. 4, 2 (2006)
251. Resina S, Prevot P, Thierry AR. Physico-chemical characteristics of lipoplexes influence cell uptake mechanisms and transfection efficacy. PLoS ONE 4(6), e6058 (2009)
252. Love KT, Mahon KP, Levins CG, et al. Lipid-like materials for low-dose, in vivo gene silencing. Proc. Natl. Acad. Sci. USA 107, 1864-1869 (2010)
253. Davis ME, Zuckerman JE, Choi CHJ, et al. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 464, 1067-1071 (2010)
254. DeNicola GM, Karreth FA, Humpton TJ, et al. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 475, 106-109 (2011)